Jafari Negar, Yousefi Ghalati Sahar, Shahabi Raberi Venus, Moalemi Saba, Amin Arash
Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.
Galen Med J. 2024 Sep 11;13:e3469. doi: 10.31661/gmj.v13i.3469. eCollection 2024.
Heart failure (HF) is a chronic and progressive condition that its management presents significant challenges in both clinical settings and patient self-care. Recent advances in wearable technology offer promising solutions to these challenges by enabling continuous monitoring, early detection of clinical deterioration, and personalized care. This review aims to critically evaluate the impact of wearable technology on HF management Materials and Methods: This narrative systematic review was conducted across multiple databases, including PubMed, Web of Science, and the Cochrane Library, to identify relevant studies published between 2010 and 2024. Studies on wearable devices for HF management and monitoring were included if they reported on clinical trials and provided data on integration into clinical workflows. Studies on other conditions or without original research data or Non-English papers were excluded.
Nine studies were evaluated in this study that were focusing on a variety of technologies ranging from consumer-grade fitness trackers to specialized bioimpedance sensors and wearable cardioverter-defibrillators. These studies demonstrate the potential of wearables to continuously monitor important health metrics, which can lead to early intervention and personalized care. However, there are still challenges to be addressed, including concerns about data accuracy, patient adherence, small sample sizes, and the incorporation of wearable data into clinical practice. While consumer devices are more accessible, their accuracy in a clinical setting is uncertain, while more advanced devices like the "Volum" monitor and BioZ sensors show promise but require further validation.
This review highlights the growing importance of wearable technologies in HF management, actionable insights that can prevent disease progression. However, significant challenges remain, including the need for further validation, device optimization, and data standardization before routine clinical practice. Future advancements should focus on improving device accuracy, patient adherence, and data security, while ensuring equitable access to these technologies.
心力衰竭（HF）是一种慢性进行性疾病，其管理在临床环境和患者自我护理方面都面临重大挑战。可穿戴技术的最新进展通过实现连续监测、临床恶化的早期检测和个性化护理，为这些挑战提供了有前景的解决方案。本综述旨在批判性地评估可穿戴技术对心力衰竭管理的影响。
本叙述性系统综述在多个数据库中进行，包括PubMed、科学网和考克兰图书馆，以识别2010年至2024年期间发表的相关研究。纳入关于用于心力衰竭管理和监测的可穿戴设备的研究，如果它们报告了临床试验并提供了融入临床工作流程的数据。排除关于其他疾病或没有原始研究数据的研究以及非英文论文。
本研究评估了9项研究，这些研究聚焦于从消费级健身追踪器到专业生物阻抗传感器和可穿戴式心脏复律除颤器等各种技术。这些研究证明了可穿戴设备连续监测重要健康指标的潜力，这可导致早期干预和个性化护理。然而，仍有挑战需要解决，包括对数据准确性、患者依从性、小样本量以及将可穿戴数据纳入临床实践的担忧。虽然消费设备更容易获得，但其在临床环境中的准确性不确定，而像“Volum”监测器和BioZ传感器等更先进的设备显示出前景，但需要进一步验证。
本综述强调了可穿戴技术在心力衰竭管理中的重要性日益增加，这些可操作的见解可预防疾病进展。然而，重大挑战仍然存在，包括在常规临床实践之前需要进一步验证、设备优化和数据标准化。未来的进展应侧重于提高设备准确性、患者依从性和数据安全性，同时确保公平获取这些技术。
